Introdução
Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Jack W Schuler. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.
Rentabilidade Média de Negociação
A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.
Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.
Frequência de Atualização: Diariamente
Empresas com Posições Internas Reportadas
As declarações à SEC indicam que Jack W Schuler reportou posses ou negociações nas seguintes empresas:
| Ativo | Título | Últimas Posições Reportadas |
|---|---|---|
| US:BDSX / Biodesix, Inc. | 10% Owner | 1,563,210 |
| US:AWHL / Aspira Women's Health Inc. | 10% Owner | 3,823,829 |
| US:AXDX / Accelerate Diagnostics, Inc. | Director, 10% Owner | 8,310,388 |
| US:YTEN / Yield10 Bioscience, Inc. | 10% Owner | 63,789 |
| US:SLNO / Soleno Therapeutics, Inc. | 10% Owner | 46,595 |
| US:QDEL / QuidelOrtho Corporation | Director, 10% Owner | 0 |
| US:BIOL / BIOLASE, Inc. | 10% Owner | 739,820 |
| US:SRCL / Stericycle, Inc. | Director | 2,078 |
| 10% Owner | 4,677,342 | |
| US:HNSN / Hansen Medical, Inc. | Director, 10% Owner | 60,000 |
| 10% Owner | 6,165,261 | |
| Director | 21,910 |
Como Interpretar os Gráficos
Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Jack W Schuler. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.
Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.
No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.
O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.
Compras Internas AWHL / Aspira Women's Health Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AWHL / Aspira Women's Health Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas AWHL / Aspira Women's Health Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AWHL / Aspira Women's Health Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas BDSX / Biodesix, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AWHL / Aspira Women's Health Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas BDSX / Biodesix, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AWHL / Aspira Women's Health Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
| Data de Negociação | Ticker | Insider | Ações Reportadas |
Preço Reportado |
Ações Ajustadas |
Preço Ajustado |
Base de Custos | Dias para Mín |
Preço em Mín |
Máxima Perda Evitada ($) |
Máxima Perda Evitada (%) |
|---|---|---|---|---|---|---|---|
| Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo |
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas QDEL / QuidelOrtho Corporation - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AWHL / Aspira Women's Health Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas QDEL / QuidelOrtho Corporation - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AWHL / Aspira Women's Health Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Compras Internas YTENQ / Yield10 Bioscience, Inc. - Análise de Lucro de Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AWHL / Aspira Women's Health Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Vendas Internas YTENQ / Yield10 Bioscience, Inc. - Análise de Perda de Curto Prazo
Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AWHL / Aspira Women's Health Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.
A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.
O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.
Histórico de Negociações Insider
Esta tabela mostra a lista completa de negociações insider realizadas por Jack W Schuler conforme divulgadas para a Comissão de Valores Mobiliários (SEC).
| Data do Arquivo | Data da Transação | Formulário | Ticker | Ativo | Código | Ações | Ações Restantes | Variação Percentual |
Preço da Ação |
Valor da Transação |
Valor Restante |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-27 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 20,000 | 1,563,210 | 1.30 | 11.80 | 236,064 | 18,450,880 | |
| 2026-01-27 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 80,000 | 1,543,210 | 5.47 | 11.81 | 944,672 | 18,222,841 | |
| 2026-01-26 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 82,465 | 1,463,210 | 5.97 | 10.96 | 903,561 | 16,032,246 | |
| 2025-09-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 142,045 | 1,380,745 | 11.47 | 7.04 | 999,997 | 9,720,445 | |
| 2025-09-19 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 3,056 | 1,238,700 | 0.25 | 6.17 | 18,854 | 7,642,160 | |
| 2025-09-19 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 15,317 | 1,235,644 | 1.26 | 6.04 | 92,571 | 7,467,862 | |
| 2025-09-19 |
|
4 | AWHL |
Aspira Women's Health Inc.
Common Stock |
P - Purchase | 1,111,111 | 3,823,829 | 40.96 | 0.45 | 500,000 | 1,720,723 | |
| 2025-09-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 3,488,372 | 24,406,546 | 16.68 | 0.43 | 1,500,000 | 10,494,815 | |
| 2025-05-20 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 723,239 | 20,918,174 | 3.58 | 0.34 | 246,624 | 7,133,097 | |
| 2025-05-20 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 4,000,000 | 20,194,935 | 24.70 | 0.27 | 1,070,000 | 5,402,145 | |
| 2024-12-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
S - Sale | -200,000 | 8,310,388 | -2.35 | 1.57 | -314,000 | 13,047,309 | |
| 2024-11-22 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 100,000 | 31,194,935 | 0.32 | 1.23 | 122,840 | 38,319,858 | |
| 2024-11-21 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 200,000 | 31,094,935 | 0.65 | 1.17 | 234,000 | 36,381,074 | |
| 2024-11-06 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 100,253 | 30,894,935 | 0.33 | 1.36 | 136,585 | 42,091,259 | |
| 2024-07-11 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock |
P - Purchase | 6,536 | 6,536 | |||||
| 2024-07-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 4,737 | 20,225 | 30.58 | ||||
| 2024-06-18 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock |
P - Purchase | 28,500 | 1,912,156 | 1.51 | ||||
| 2024-05-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 7,894 | 15,488 | 103.95 | ||||
| 2024-05-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
M - Exercise | 86,960 | 30,794,682 | 0.28 | ||||
| 2024-05-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 1,560,694 | 8,510,388 | 22.46 | ||||
| 2024-05-17 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -36,000 | 63,789 | -36.08 | 0.20 | -7,200 | 12,758 | |
| 2024-01-25 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 1,156,069 | 6,949,694 | 19.95 | ||||
| 2023-12-20 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -36,000 | 1,566,956 | -2.25 | 0.21 | -7,430 | 323,420 | |
| 2023-12-11 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -35,000 | 1,602,956 | -2.14 | 0.24 | -8,320 | 381,023 | |
| 2023-10-10 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 765,000 | 1,637,956 | 87.63 | 0.65 | 497,250 | 1,064,671 | |
| 2023-10-06 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -37,931 | 872,956 | -4.16 | 0.30 | -11,448 | 263,458 | |
| 2023-10-06 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -10,670 | 910,887 | -1.16 | 0.30 | -3,216 | 274,541 | |
| 2023-10-06 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -41,399 | 921,557 | -4.30 | 0.31 | -12,867 | 286,420 | |
| 2023-08-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 87,500 | 30,707,722 | 0.29 | 1.71 | 149,240 | 52,375,091 | |
| 2023-08-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 8,307 | 30,620,222 | 0.03 | 1.67 | 13,859 | 51,083,716 | |
| 2023-08-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 32,556 | 30,611,915 | 0.11 | 1.64 | 53,411 | 50,221,908 | |
| 2023-08-11 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
A - Award | 9,989,506 | 30,579,359 | 48.52 | 1.62 | 16,183,000 | 49,538,562 | |
| 2023-07-25 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock, par value $0.001 |
P - Purchase | 181,800 | 1,883,656 | 10.68 | 2.75 | 499,950 | 5,180,054 | |
| 2023-06-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 34,321,163 | 57,936,258 | 145.34 | 1.06 | 36,380,433 | 61,412,433 | |
| 2023-06-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 4,878,048 | 23,615,095 | 26.03 | 0.82 | 3,999,999 | 19,364,378 | |
| 2023-06-01 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 14,792 | 20,589,853 | 0.07 | 1.35 | 20,006 | 27,847,776 | |
| 2023-06-01 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 11,849 | 20,575,061 | 0.06 | 1.36 | 16,150 | 28,043,808 | |
| 2023-06-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 75,949 | 75,949 | |||||
| 2023-05-30 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 52,508 | 20,563,212 | 0.26 | 1.36 | 71,280 | 27,914,560 | |
| 2023-05-26 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 35,308 | 20,510,704 | 0.17 | 1.25 | 43,980 | 25,548,133 | |
| 2023-05-25 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 56,782 | 20,475,396 | 0.28 | 1.15 | 65,066 | 23,462,756 | |
| 2023-05-24 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 29,425 | 20,418,614 | 0.14 | 1.11 | 32,529 | 22,572,778 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 46,595 | -17.67 | 0.93 | -9,300 | 43,333 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 56,595 | -15.02 | 0.96 | -9,600 | 54,331 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 66,595 | -13.06 | 0.99 | -9,900 | 65,929 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 76,595 | -11.55 | 0.97 | -9,700 | 74,297 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 86,595 | -10.35 | 1.00 | -10,000 | 86,595 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 96,595 | -9.38 | 1.03 | -10,300 | 99,493 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 106,595 | -8.58 | 0.99 | -9,900 | 105,529 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 116,595 | -7.90 | 1.01 | -10,100 | 117,761 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 126,595 | -7.32 | 1.05 | -10,500 | 132,925 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 136,595 | -6.82 | 1.07 | -10,700 | 146,157 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,400 | 146,595 | -6.62 | 1.11 | -11,544 | 162,720 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 156,995 | -5.99 | 1.07 | -10,700 | 167,985 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -14,531 | 166,995 | -8.00 | 1.13 | -16,420 | 188,704 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -28,474 | 181,526 | -13.56 | 1.15 | -32,745 | 208,755 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -11,442 | 210,000 | -5.17 | 1.15 | -13,158 | 241,500 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -116,882 | 221,442 | -34.55 | 1.26 | -147,271 | 279,017 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 338,324 | -2.87 | 1.09 | -10,900 | 368,773 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 348,324 | -2.79 | 1.07 | -10,700 | 372,707 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 358,324 | -2.72 | 0.94 | -9,400 | 336,825 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 368,324 | -2.64 | 0.99 | -9,900 | 364,641 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 378,324 | -2.58 | 0.99 | -9,900 | 374,541 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 388,324 | -2.51 | 0.99 | -9,900 | 384,441 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 398,324 | -2.45 | 1.01 | -10,100 | 402,307 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 408,324 | -2.39 | 0.97 | -9,700 | 396,074 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 418,324 | -2.33 | 0.99 | -9,900 | 414,141 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 428,324 | -2.28 | 1.00 | -10,000 | 428,324 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 438,324 | -2.23 | 1.08 | -10,800 | 473,390 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -9,100 | 448,324 | -1.99 | 1.16 | -10,556 | 520,056 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -8,842 | 457,424 | -1.90 | 1.26 | -11,141 | 576,354 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -400 | 466,266 | -0.09 | 1.52 | -608 | 708,724 | |
| 2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,000 | 36,595 | -21.46 | 0.91 | -9,100 | 33,301 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 708,858 | -0.42 | 2.19 | -6,570 | 1,552,399 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 711,858 | -0.42 | 2.33 | -6,990 | 1,658,629 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 714,858 | -0.42 | 2.36 | -7,080 | 1,687,065 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 717,858 | -0.42 | 2.47 | -7,410 | 1,773,109 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 720,858 | -0.41 | 2.44 | -7,320 | 1,758,894 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 723,858 | -0.41 | 2.72 | -8,160 | 1,968,894 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 726,858 | -0.41 | 2.70 | -8,100 | 1,962,517 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,400 | 729,858 | -0.46 | 2.41 | -8,194 | 1,758,958 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 733,258 | -0.41 | 2.49 | -7,470 | 1,825,812 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 736,258 | -0.41 | 2.45 | -7,350 | 1,803,832 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -1,400 | 739,258 | -0.19 | 2.53 | -3,542 | 1,870,323 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 740,658 | -0.40 | 2.81 | -8,430 | 2,081,249 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 743,658 | -0.40 | 2.97 | -8,910 | 2,208,664 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -9,851 | 746,658 | -1.30 | 3.01 | -29,652 | 2,247,441 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -4,158 | 756,509 | -0.55 | 3.01 | -12,516 | 2,277,092 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -4,000 | 760,667 | -0.52 | 3.03 | -12,120 | 2,304,821 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -7,420 | 764,667 | -0.96 | 3.03 | -22,483 | 2,316,941 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,141 | 772,087 | -0.41 | 3.07 | -9,643 | 2,370,307 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -4,625 | 775,228 | -0.59 | 3.06 | -14,152 | 2,372,198 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -20,338 | 779,853 | -2.54 | 3.09 | -62,844 | 2,409,746 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -4,200 | 800,191 | -0.52 | 3.14 | -13,188 | 2,512,600 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -4,259 | 804,391 | -0.53 | 3.22 | -13,714 | 2,590,139 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -13,822 | 808,650 | -1.68 | 3.35 | -46,304 | 2,708,978 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -25,343 | 822,472 | -2.99 | 3.34 | -84,646 | 2,747,056 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 847,815 | -0.35 | 3.20 | -9,600 | 2,713,008 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,000 | 850,815 | -0.35 | 2.88 | -8,640 | 2,450,347 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -1,200 | 853,815 | -0.14 | 2.85 | -3,420 | 2,433,373 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -900 | 855,015 | -0.11 | 2.96 | -2,664 | 2,530,844 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -200 | 855,915 | -0.02 | 2.90 | -580 | 2,482,154 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -4,901 | 856,115 | -0.57 | 2.96 | -14,507 | 2,534,100 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -608 | 627,386 | -0.10 | 1.78 | -1,082 | 1,116,747 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -5,100 | 627,994 | -0.81 | 1.76 | -8,976 | 1,105,269 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -7,000 | 633,094 | -1.09 | 1.82 | -12,740 | 1,152,231 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -6,324 | 640,094 | -0.98 | 1.88 | -11,889 | 1,203,377 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -18,192 | 646,418 | -2.74 | 1.89 | -34,383 | 1,221,730 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -7,000 | 664,610 | -1.04 | 1.75 | -12,250 | 1,163,068 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -4,292 | 671,610 | -0.64 | 1.80 | -7,726 | 1,208,898 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -10,152 | 675,902 | -1.48 | 1.88 | -19,086 | 1,270,696 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -5,300 | 686,054 | -0.77 | 1.91 | -10,123 | 1,310,363 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -3,504 | 691,354 | -0.50 | 1.91 | -6,693 | 1,320,486 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -7,000 | 694,858 | -1.00 | 1.96 | -13,720 | 1,361,922 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -7,000 | 701,858 | -0.99 | 2.06 | -14,420 | 1,445,827 | |
| 2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 335,570 | 962,956 | 53.49 | 2.98 | 999,999 | 2,869,609 | |
| 2023-02-01 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 10,000 | 20,389,189 | 0.05 | 2.41 | 24,100 | 49,137,945 | |
| 2023-01-31 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 50,000 | 20,379,189 | 0.25 | 2.51 | 125,430 | 51,123,234 | |
| 2023-01-31 |
|
4/A | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 10,000 | 20,319,189 | 0.05 | 1.65 | 16,476 | 33,477,896 | |
| 2022-12-20 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 10,000 | 20,339,189 | 0.05 | 1.70 | 17,000 | 34,576,621 | |
| 2022-12-19 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 20,000 | 20,329,189 | 0.10 | 1.65 | 32,952 | 33,494,372 | |
| 2022-12-16 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 189,675 | 20,309,189 | 0.94 | 1.65 | 312,945 | 33,508,131 | |
| 2022-12-15 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 67,402 | 20,119,514 | 0.34 | 1.58 | 106,529 | 31,798,892 | |
| 2022-12-14 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 100,000 | 20,052,112 | 0.50 | 1.48 | 148,380 | 29,753,324 | |
| 2022-11-21 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 8,695,652 | 19,952,112 | 77.25 | 1.15 | 10,000,000 | 22,944,929 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -22,681 | 466,666 | -4.63 | 2.41 | -54,675 | 1,124,945 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -8,394 | 489,347 | -1.69 | 2.42 | -20,345 | 1,186,030 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,888 | 497,741 | -2.14 | 2.50 | -27,231 | 1,244,850 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -173 | 508,629 | -0.03 | 2.62 | -454 | 1,334,693 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -4,571 | 508,802 | -0.89 | 2.68 | -12,231 | 1,361,402 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -7,876 | 513,373 | -1.51 | 2.73 | -21,493 | 1,400,944 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -10,833 | 521,249 | -2.04 | 2.80 | -30,372 | 1,461,426 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -5,212 | 532,082 | -0.97 | 2.90 | -15,105 | 1,542,027 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -7,718 | 537,294 | -1.42 | 2.88 | -22,245 | 1,548,589 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -53,333 | 545,012 | -8.91 | 2.93 | -156,378 | 1,598,030 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -16,667 | 598,345 | -2.71 | 2.65 | -44,238 | 1,588,127 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -2,675 | 615,012 | -0.43 | 2.72 | -7,264 | 1,670,004 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -8,006 | 617,687 | -1.28 | 2.65 | -21,184 | 1,634,400 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -6,824 | 625,693 | -1.08 | 2.64 | -18,014 | 1,651,704 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -6,696 | 632,517 | -1.05 | 2.52 | -16,894 | 1,595,840 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -5,103 | 639,213 | -0.79 | 2.46 | -12,551 | 1,572,208 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -2,520 | 644,316 | -0.39 | 2.54 | -6,389 | 1,633,534 | |
| 2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -353 | 646,836 | -0.05 | 2.55 | -901 | 1,650,984 | |
| 2022-08-29 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock, par value $0.001 |
P - Purchase | 133,333 | 25,527,850 | 0.53 | ||||
| 2022-05-26 |
|
4 | BDSX |
BIODESIX INC
Restricted Stock Units |
A - Award | 83,333 | 83,333 | |||||
| 2022-04-11 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 2,793,296 | 11,256,460 | 33.01 | 1.79 | 5,000,000 | 20,149,063 | |
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 4,000,000 | 4,000,000 | |||||
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 4,000,000 | 7,911,804 | 102.25 | ||||
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -800 | 3,911,804 | -0.02 | 0.35 | -284 | 1,387,908 | |
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -100,000 | 3,912,604 | -2.49 | 0.88 | -87,600 | 3,427,441 | |
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -2,599 | 4,012,604 | -0.06 | 0.87 | -2,270 | 3,505,010 | |
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -49,841 | 4,015,203 | -1.23 | 0.78 | -39,120 | 3,151,533 | |
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -19,748 | 4,065,044 | -0.48 | 0.86 | -17,074 | 3,514,637 | |
| 2022-01-31 |
|
4/A | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 2,298,850 | 8,463,164 | 37.29 | 4.35 | 9,999,998 | 36,814,763 | |
| 2022-01-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 41,912 | 18,737,047 | 0.22 | 3.94 | 165,133 | 73,823,965 | |
| 2022-01-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 31,219 | 18,695,135 | 0.17 | 3.89 | 121,442 | 72,724,075 | |
| 2022-01-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100,000 | 18,663,916 | 0.54 | 4.03 | 403,000 | 75,215,581 | |
| 2022-01-12 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 45,226 | 18,563,916 | 0.24 | 4.34 | 196,281 | 80,567,395 | |
| 2022-01-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 18,518,690 | 0.05 | 4.93 | 49,300 | 91,297,142 | |
| 2022-01-04 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 997 | 18,508,690 | 0.01 | 4.95 | 4,935 | 91,618,016 | |
| 2022-01-04 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 2,298,850 | 8,463,164 | 37.29 | 4.35 | 9,999,998 | 36,814,763 | |
| 2021-12-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 27,062 | 18,507,693 | 0.15 | 4.83 | 130,709 | 89,392,157 | |
| 2021-12-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 30,000 | 18,480,631 | 0.16 | 4.87 | 146,100 | 90,000,673 | |
| 2021-12-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 54,541 | 18,450,631 | 0.30 | 4.73 | 257,979 | 87,271,485 | |
| 2021-12-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 74,127 | 18,396,090 | 0.40 | 4.98 | 369,152 | 91,612,528 | |
| 2021-12-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20,000 | 18,321,963 | 0.11 | 4.60 | 92,000 | 84,281,030 | |
| 2021-12-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 17,050 | 18,301,963 | 0.09 | 4.38 | 74,679 | 80,162,598 | |
| 2021-11-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1,000,000 | 18,284,913 | 5.79 | 5.00 | 5,000,000 | 91,424,565 | |
| 2021-11-24 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 20,000 | 6,164,314 | 0.33 | 6.34 | 126,756 | 39,068,189 | |
| 2021-11-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 48,987 | 17,284,913 | 0.28 | 5.06 | 247,874 | 87,461,660 | |
| 2021-11-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 60,000 | 6,144,314 | 0.99 | 6.50 | 390,186 | 39,957,088 | |
| 2021-11-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 56,850 | 17,235,926 | 0.33 | 5.19 | 295,052 | 89,454,456 | |
| 2021-11-22 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 28,361 | 6,084,314 | 0.47 | 6.33 | 179,502 | 38,508,840 | |
| 2021-11-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 116,444 | 17,179,076 | 0.68 | 5.20 | 605,509 | 89,331,195 | |
| 2021-11-19 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 20,000 | 6,055,953 | 0.33 | 6.51 | 130,104 | 39,395,185 | |
| 2021-10-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 54,975 | 54,975 | 9.08 | 499,173 | 499,173 | ||
| 2021-10-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
G - Gift | -689,355 | 0 | -100.00 | ||||
| 2021-09-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 59,978 | 17,062,632 | 0.35 | 5.31 | 318,483 | 90,602,576 | |
| 2021-09-29 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 150,000 | 17,002,654 | 0.89 | 5.33 | 799,500 | 90,624,146 | |
| 2021-09-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 192,200 | 16,852,654 | 1.15 | 5.45 | 1,047,490 | 91,846,964 | |
| 2021-09-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 27,353 | 16,660,454 | 0.16 | 5.50 | 150,442 | 91,632,497 | |
| 2021-08-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 50,000 | 6,035,953 | 0.84 | 7.69 | 384,440 | 46,409,235 | |
| 2021-08-19 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 29,440 | 5,985,953 | 0.49 | 7.18 | 211,447 | 42,992,910 | |
| 2021-08-17 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 232,000 | 5,956,513 | 4.05 | 7.50 | 1,739,490 | 44,660,743 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -41,195 | 9,707,848 | -0.42 | 1.03 | -42,456 | 10,004,908 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -248,115 | 9,749,043 | -2.48 | 1.14 | -283,149 | 11,125,608 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -5,625 | 9,997,158 | -0.06 | 1.25 | -7,031 | 12,496,448 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -80,498 | 10,002,783 | -0.80 | 1.26 | -101,065 | 12,558,494 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -250,000 | 10,083,281 | -2.42 | 1.20 | -300,425 | 12,117,079 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -248,636 | 10,333,281 | -2.35 | 1.21 | -300,800 | 12,501,203 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -187,985 | 4,084,792 | -4.40 | 2.67 | -501,920 | 10,906,395 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -172,717 | 4,272,777 | -3.89 | 2.62 | -452,570 | 11,195,958 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -200 | 10,581,917 | 0.00 | 2.71 | -542 | 28,676,995 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -700 | 4,445,494 | -0.02 | 2.97 | -2,079 | 13,205,784 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -258,300 | 10,582,117 | -2.38 | 2.95 | -762,527 | 31,239,468 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -14,700 | 4,446,194 | -0.33 | 2.13 | -31,312 | 9,470,838 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -100 | 10,840,417 | 0.00 | 2.05 | -205 | 22,222,855 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -12,763 | 10,840,517 | -0.12 | 2.05 | -26,209 | 22,261,002 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -12,818 | 10,853,280 | -0.12 | 2.06 | -26,363 | 22,321,941 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -72,591 | 10,866,098 | -0.66 | 2.09 | -151,592 | 22,691,672 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -15,566 | 10,938,689 | -0.14 | 2.10 | -32,642 | 22,938,431 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -20,277 | 10,954,255 | -0.18 | 2.10 | -42,484 | 22,951,355 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -29,723 | 10,974,532 | -0.27 | 2.05 | -61,078 | 22,551,566 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -35,231 | 4,460,894 | -0.78 | 2.11 | -74,436 | 9,424,977 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -102,000 | 11,004,255 | -0.92 | 1.99 | -203,153 | 21,917,175 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -98,862 | 11,106,255 | -0.88 | 1.90 | -188,194 | 21,141,867 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -520 | 11,205,117 | 0.00 | 1.95 | -1,014 | 21,845,496 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -33,697 | 11,205,637 | -0.30 | 1.95 | -65,783 | 21,875,645 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -63,746 | 11,239,334 | -0.56 | 1.85 | -118,185 | 20,837,725 | |
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | -65,782 | 11,303,080 | -0.58 | 1.91 | -125,367 | 21,541,410 | |
| 2021-07-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 29,577 | 16,633,101 | 0.18 | 9.20 | 272,108 | 153,024,529 | |
| 2021-07-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5,000 | 1,267,023 | 0.40 | 16.04 | 80,200 | 20,323,049 | |
| 2021-07-01 |
|
4 | BDSX |
BIODESIX INC
Stock Options (Right to buy) |
A - Award | 34,385 | 34,385 | |||||
| 2021-05-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 35,168 | 35,168 | |||||
| 2021-02-04 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 54,132 | 1,262,023 | 4.48 | 9.87 | 534,283 | 12,456,167 | |
| 2021-02-04 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 101,400 | 895,035 | 12.78 | 12.25 | 1,242,150 | 10,964,179 | |
| 2021-02-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 100,000 | 1,207,891 | 9.03 | 11.40 | 1,140,000 | 13,769,957 | |
| 2021-02-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 30,868 | 1,107,891 | 2.87 | 10.18 | 314,236 | 11,278,330 | |
| 2020-12-09 |
|
4 | BDSX |
BIODESIX INC
Stock Options (Right to Buy) |
M - Exercise | -23,440 | 11,718 | -66.67 | ||||
| 2020-12-09 |
|
4 | BDSX |
BIODESIX INC
Stock Options (Right to Buy) |
M - Exercise | -35,157 | 1 | -100.00 | ||||
| 2020-12-09 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
M - Exercise | 23,440 | 5,725,419 | 0.41 | 6.83 | 160,095 | 39,104,612 | |
| 2020-12-09 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
M - Exercise | 35,157 | 5,701,979 | 0.62 | 6.83 | 240,122 | 38,944,517 | |
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series B Preferred Stock |
C - Conversion | -1,454,545 | 0 | -100.00 | ||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
3% Convertible Debt due June 2021 |
C - Conversion | 0 | ||||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series H Preferred Stock |
C - Conversion | -5,366,411 | 0 | -100.00 | ||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series G Preferred Stock |
C - Conversion | -9,419,362 | 0 | -100.00 | ||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series F Preferred Stock |
C - Conversion | -6,273,780 | 0 | -100.00 | ||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series E Preferred Stock |
C - Conversion | -1,759,853 | 0 | -100.00 | ||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series D Preferred Stock |
C - Conversion | -3,101,784 | 0 | -100.00 | ||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series C Preferred Stock |
C - Conversion | -333,333 | 0 | -100.00 | ||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series B-1 Preferred Stock |
C - Conversion | -1,250,000 | 0 | -100.00 | ||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 277,777 | 277,777 | 18.00 | 4,999,986 | 4,999,986 | ||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
C - Conversion | 753,735 | 5,666,822 | 15.34 | 14.40 | 10,853,784 | 81,602,237 | |
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
C - Conversion | 245,041 | 4,913,087 | 5.25 | ||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
C - Conversion | 4,668,046 | 4,668,046 | |||||
| 2020-11-03 |
|
4 | BDSX |
BIODESIX INC
3% Convertible Debt due June 2021 |
A - Award | |||||||
| 2020-08-31 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 365,241 | 793,635 | 85.26 | 4.25 | 1,552,274 | 3,372,949 | |
| 2020-07-06 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock, par value $0.001 |
P - Purchase | 2,285,715 | 25,394,517 | 9.89 | 3.50 | 8,000,002 | 88,880,810 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 33,900 | 835,717 | 4.23 | 1.93 | 65,376 | 1,611,680 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 10,572 | 801,817 | 1.34 | 1.99 | 20,991 | 1,592,008 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 800 | 791,245 | 0.10 | 2.00 | 1,600 | 1,582,490 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 7,300 | 790,445 | 0.93 | 2.00 | 14,600 | 1,580,890 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 200 | 783,145 | 0.03 | 1.99 | 398 | 1,558,459 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 800 | 782,945 | 0.10 | 1.98 | 1,581 | 1,547,334 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 200 | 782,145 | 0.03 | 1.96 | 392 | 1,533,004 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 8,448 | 781,945 | 1.09 | 1.97 | 16,629 | 1,539,181 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 1,200 | 773,497 | 0.16 | 1.99 | 2,388 | 1,539,259 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 5,000 | 772,297 | 0.65 | 2.03 | 10,130 | 1,564,596 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 10,818 | 767,297 | 1.43 | 1.99 | 21,517 | 1,526,154 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 4,548 | 756,479 | 0.60 | 1.96 | 8,913 | 1,482,472 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 20,769 | 751,931 | 2.84 | 1.94 | 40,327 | 1,460,024 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 10,562 | 731,162 | 1.47 | 1.99 | 20,981 | 1,452,453 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 21,953 | 720,600 | 3.14 | 1.99 | 43,675 | 1,433,634 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 6,000 | 698,647 | 0.87 | 2.08 | 12,496 | 1,455,072 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 2,100 | 692,647 | 0.30 | 2.03 | 4,262 | 1,405,727 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 47,293 | 690,547 | 7.35 | 2.05 | 97,026 | 1,416,726 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 30,000 | 643,254 | 4.89 | 2.14 | 64,197 | 1,376,499 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 10,000 | 613,254 | 1.66 | 2.09 | 20,871 | 1,279,922 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 5,000 | 603,254 | 0.84 | 1.95 | 9,748 | 1,176,164 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 146,230 | 598,254 | 32.35 | 1.96 | 286,260 | 1,171,142 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 11,243 | 452,024 | 2.55 | 2.09 | 23,492 | 944,504 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 8,970 | 440,781 | 2.08 | 2.11 | 18,936 | 930,489 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 100,000 | 431,811 | 30.14 | 2.05 | 204,580 | 883,399 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 42,745 | 331,811 | 14.79 | 2.23 | 95,415 | 740,669 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 30,014 | 289,066 | 11.59 | 2.31 | 69,347 | 667,887 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 147,645 | 259,052 | 132.53 | 2.37 | 350,155 | 614,368 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 111,407 | 111,407 | 2.32 | 258,275 | 258,275 | ||
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 1,666,667 | 6,217,345 | 36.62 | 1.20 | 2,000,000 | 7,460,814 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 897,083 | 1,732,800 | 107.34 | 1.20 | 1,076,500 | 2,079,360 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 2,424,242 | 4,157,042 | 139.90 | 1.65 | 3,999,999 | 6,859,119 | |
| 2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 5,151,517 | 11,368,862 | 82.86 | 1.65 | 8,500,003 | 18,758,622 | |
| 2020-06-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 95,492 | 16,603,524 | 0.58 | 9.86 | 941,551 | 163,710,747 | |
| 2020-06-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 134,080 | 16,508,032 | 0.82 | 9.34 | 1,252,307 | 154,185,019 | |
| 2020-06-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 129,000 | 16,373,952 | 0.79 | 9.18 | 1,184,220 | 150,312,879 | |
| 2020-06-12 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100,000 | 16,244,952 | 0.62 | 9.84 | 984,000 | 159,850,328 | |
| 2020-06-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 339,083 | 2,071,883 | 19.57 | 1.97 | 666,807 | 4,074,358 | |
| 2020-06-11 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 180,955 | 16,144,952 | 1.13 | 9.63 | 1,742,597 | 155,475,888 | |
| 2020-06-11 |
|
4 | VRML |
Aspira Women's Health Inc.
Warrants (Right to buy) |
X - Other | -730,560 | 0 | -100.00 | ||||
| 2020-06-11 |
|
4 | VRML |
Aspira Women's Health Inc.
Common Stock, par value $0.001 |
X - Other | 730,560 | 23,108,802 | 3.26 | 1.80 | 1,315,008 | 41,595,844 | |
| 2020-06-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1,100,000 | 15,963,997 | 7.40 | 8.58 | 9,438,000 | 136,971,094 | |
| 2020-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units |
M - Exercise | -2,100 | 0 | -100.00 | ||||
| 2020-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 2,100 | 3,103,249 | 0.07 | ||||
| 2020-05-15 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
S - Sale | -1,307,931 | 739,820 | -63.87 | 0.60 | -784,759 | 443,892 | |
| 2020-05-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 89,055 | 14,863,997 | 0.60 | 9.46 | 842,460 | 140,613,412 | |
| 2020-05-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20,000 | 14,774,942 | 0.14 | 9.92 | 198,400 | 146,567,425 | |
| 2020-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 1,040 | 1,040 | |||||
| 2020-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 82 | 82 | |||||
| 2020-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 273 | 273 | |||||
| 2020-05-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20,000 | 14,754,942 | 0.14 | 9.99 | 199,800 | 147,401,871 | |
| 2020-05-11 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 25,000 | 14,734,942 | 0.17 | 9.87 | 246,750 | 145,433,878 | |
| 2020-05-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,868 | 14,709,942 | 0.07 | 10.00 | 108,680 | 147,099,420 | |
| 2020-05-07 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 8,625 | 14,699,074 | 0.06 | 10.00 | 86,250 | 146,990,740 | |
| 2020-05-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1,204 | 14,690,449 | 0.01 | 9.98 | 12,016 | 146,610,681 | |
| 2020-05-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 4,000 | 14,689,245 | 0.03 | 10.03 | 40,120 | 147,333,127 | |
| 2020-04-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 5,001 | 14,685,245 | 0.03 | 10.00 | 50,010 | 146,852,450 | |
| 2020-04-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 81,621 | 14,680,244 | 0.56 | 9.90 | 808,048 | 145,334,416 | |
| 2020-04-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 157,688 | 14,598,623 | 1.09 | 9.47 | 1,493,305 | 138,248,960 | |
| 2020-04-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 79,650 | 14,440,935 | 0.55 | 9.01 | 717,646 | 130,112,824 | |
| 2020-04-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 59,357 | 14,361,285 | 0.42 | 9.40 | 557,956 | 134,996,079 | |
| 2020-04-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
G - Gift | -1,100,000 | 1,077,023 | -50.53 | ||||
| 2020-04-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 13,779 | 13,779 | |||||
| 2020-04-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 120,000 | 14,301,928 | 0.85 | 8.30 | 996,000 | 118,706,002 | |
| 2020-04-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 80,000 | 14,181,928 | 0.57 | 8.59 | 687,200 | 121,822,762 | |
| 2020-03-31 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 101,963 | 14,101,928 | 0.73 | 8.09 | 824,881 | 114,084,598 | |
| 2020-03-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 148,037 | 13,999,965 | 1.07 | 8.04 | 1,190,217 | 112,559,719 | |
| 2020-03-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 12,290 | 12,290 | |||||
| 2020-03-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 150,000 | 13,851,928 | 1.09 | 7.70 | 1,155,000 | 106,659,846 | |
| 2020-03-27 |
|
4/A | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 150,000 | 13,701,928 | 1.11 | 6.92 | 1,038,000 | 94,817,342 | |
| 2020-03-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 150,000 | 13,701,928 | 1.11 | 6.92 | 1,038,000 | 94,817,342 | |
| 2020-03-25 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 172,900 | 13,551,928 | 1.29 | 5.89 | 1,018,381 | 79,820,856 | |
| 2020-02-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 9,000 | 13,379,028 | 0.07 | 15.39 | 138,510 | 205,903,241 | |
| 2020-02-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 10,000 | 13,370,028 | 0.07 | 15.84 | 158,400 | 211,781,244 | |
| 2020-02-25 |
|
4/A | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 13,360,028 | 0.07 | 16.32 | 163,200 | 218,035,657 | |
| 2020-02-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 13,350,028 | 0.07 | 16.06 | 160,600 | 214,401,450 | |
| 2020-02-12 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -42,697 | 428,396 | -9.06 | 7.69 | -328,225 | 3,293,209 | |
| 2020-02-12 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | -28,256 | 471,093 | -5.66 | 7.90 | -223,180 | 3,720,928 | |
| 2020-02-12 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 9,852 | 489,496 | 2.05 | 7.90 | 77,880 | 3,869,466 | |
| 2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Series B Convertible Preferred Stock |
C - Conversion | -3,155 | 0 | -100.00 | 1,000.00 | -3,155,000 | ||
| 2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
C - Conversion | 374,375 | 489,946 | 323.94 | ||||
| 2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Series B Convertible Preferred Stock |
P - Purchase | 3,155 | 3,155 | 1,000.00 | 3,155,000 | 3,155,000 | ||
| 2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Series B Warrants |
P - Purchase | 3,155 | 3,155 | 1,000.00 | 3,155,000 | 3,155,000 | ||
| 2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Series A Warrants |
P - Purchase | 3,155 | 3,155 | 1,000.00 | 3,155,000 | 3,155,000 | ||
| 2019-12-11 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5,000 | 2,177,023 | 0.23 | 15.72 | 78,600 | 34,222,802 | |
| 2019-12-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5,000 | 2,172,023 | 0.23 | 15.94 | 79,700 | 34,622,047 | |
| 2019-11-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5,000 | 2,167,023 | 0.23 | 15.75 | 78,750 | 34,130,612 | |
| 2019-11-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
2.50% Convertible Senior Notes due 2023 |
J - Other | 1,506,194.00 | ||||||
| 2019-11-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5,000 | 2,162,023 | 0.23 | 15.32 | 76,600 | 33,122,192 | |
| 2019-11-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 2,157,023 | 0.47 | 15.18 | 151,800 | 32,743,609 | |
| 2019-08-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 2,147,023 | 0.47 | 18.00 | 180,000 | 38,646,414 | |
| 2019-08-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5,000 | 2,137,023 | 0.23 | 18.29 | 91,450 | 39,086,151 | |
| 2019-08-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5,000 | 2,132,023 | 0.24 | 18.37 | 91,850 | 39,165,263 | |
| 2019-08-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 2,127,023 | 0.47 | 17.89 | 178,900 | 38,052,441 | |
| 2019-08-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5,000 | 2,117,023 | 0.24 | 18.20 | 91,000 | 38,529,819 | |
| 2019-08-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5,000 | 2,112,023 | 0.24 | 18.08 | 90,400 | 38,185,376 | |
| 2019-08-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 2,107,023 | 0.48 | 17.45 | 174,500 | 36,767,551 | |
| 2019-07-02 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
P - Purchase | 5,000,000 | 22,378,242 | 28.77 | 0.80 | 4,000,000 | 17,902,594 | |
| 2019-06-05 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 552,427 | 3,822,908 | 16.89 | 1.21 | 668,492 | 4,626,101 | |
| 2019-06-05 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock Warrants |
P - Purchase | 1,906,744 | 2,366,838 | 414.42 | 0.05 | 95,337 | 118,342 | |
| 2019-06-05 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 1,906,744 | 3,270,481 | 139.82 | 2.26 | 4,309,241 | 7,391,287 | |
| 2019-06-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,700 | 2,097,023 | 0.51 | 18.77 | 200,839 | 39,361,122 | |
| 2019-05-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 32,600 | 2,086,323 | 1.59 | 18.87 | 615,162 | 39,368,915 | |
| 2019-05-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 2,053,723 | 0.49 | 19.06 | 190,600 | 39,143,960 | |
| 2019-05-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 19,300 | 2,043,723 | 0.95 | 19.02 | 367,086 | 38,871,611 | |
| 2019-05-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 50,000 | 2,024,423 | 2.53 | 19.03 | 951,500 | 38,524,770 | |
| 2019-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 1,661 | 3,101,149 | 0.05 | ||||
| 2019-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 2,100 | 2,100 | |||||
| 2019-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 262 | 262 | |||||
| 2019-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 875 | 875 | |||||
| 2019-02-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 1,974,423 | 0.51 | 18.48 | 184,800 | 36,487,337 | |
| 2019-01-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20,000 | 1,964,423 | 1.03 | 14.57 | 291,400 | 28,621,643 | |
| 2018-12-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20,000 | 1,944,423 | 1.04 | 10.53 | 210,600 | 20,474,774 | |
| 2018-12-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20,000 | 1,924,423 | 1.05 | 10.44 | 208,800 | 20,090,976 | |
| 2018-12-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock Warrant (Right to Buy) |
P - Purchase | 151,550 | 1,276,110 | 13.48 | ||||
| 2018-12-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share ("Common Stock") |
P - Purchase | 3,031,002 | 4,550,678 | 199.45 | 1.61 | 4,868,699 | 7,309,754 | |
| 2018-12-26 | 3 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
3,039,352 | ||||||||
| 2018-12-26 | 3 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
3,039,352 | ||||||||
| 2018-12-26 | 3 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
3,039,352 | ||||||||
| 2018-12-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20,000 | 1,904,423 | 1.06 | 10.88 | 217,600 | 20,720,122 | |
| 2018-12-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20,000 | 1,884,423 | 1.07 | 11.21 | 224,200 | 21,124,382 | |
| 2018-12-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 25,000 | 1,864,423 | 1.36 | 11.86 | 296,500 | 22,112,057 | |
| 2018-12-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 25,000 | 1,839,423 | 1.38 | 12.37 | 309,250 | 22,753,663 | |
| 2018-12-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 15,000 | 1,814,423 | 0.83 | 12.86 | 192,900 | 23,333,480 | |
| 2018-12-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 50,000 | 1,799,423 | 2.86 | 13.23 | 661,500 | 23,806,366 | |
| 2018-12-12 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 34,000 | 1,749,423 | 1.98 | 13.83 | 470,220 | 24,194,520 | |
| 2018-12-11 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 1,715,423 | 0.59 | 13.89 | 138,900 | 23,827,225 | |
| 2018-12-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 1,705,423 | 0.59 | 13.97 | 139,700 | 23,824,759 | |
| 2018-11-29 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 1,695,423 | 0.59 | 12.95 | 129,500 | 21,955,728 | |
| 2018-11-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10,000 | 1,685,423 | 0.60 | 12.98 | 129,800 | 21,876,791 | |
| 2018-11-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 25,000 | 1,675,423 | 1.51 | 12.95 | 323,750 | 21,696,728 | |
| 2018-11-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20,000 | 1,650,423 | 1.23 | 14.24 | 284,800 | 23,502,024 | |
| 2018-11-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 19,500 | 1,630,423 | 1.21 | 14.37 | 280,215 | 23,429,179 | |
| 2018-11-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 80,500 | 1,610,923 | 5.26 | 15.01 | 1,208,305 | 24,179,954 | |
| 2018-06-25 |
|
4 | VRML |
VERMILLION, INC.
Series B Convertible Preferred Stock (Right to Buy) |
C - Conversion | -39,619 | 0 | -100.00 | ||||
| 2018-06-25 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
C - Conversion | 3,961,900 | 17,378,242 | 29.53 | 1.00 | 3,961,900 | 17,378,242 | |
| 2018-05-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 13,340,028 | 0.08 | 20.00 | 200,000 | 266,800,560 | |
| 2018-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 1,661 | 1,661 | |||||
| 2018-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 200 | 200 | |||||
| 2018-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 667 | 667 | |||||
| 2018-05-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 65,000 | 13,330,028 | 0.49 | 19.97 | 1,298,050 | 266,200,659 | |
| 2018-05-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 22,200 | 13,265,028 | 0.17 | 19.88 | 441,336 | 263,708,757 | |
| 2018-05-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 77,800 | 13,242,828 | 0.59 | 19.17 | 1,491,426 | 253,865,013 | |
| 2018-05-02 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 170 | 2,078 | 8.91 | ||||
| 2018-04-19 |
|
4 | VRML |
VERMILLION, INC.
Series B Convertible Preferred Stock (Right to Buy) |
P - Purchase | 39,619 | 39,619 | 100.00 | 3,961,900 | 3,961,900 | ||
| 2018-04-19 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
P - Purchase | 2,838,090 | 13,416,342 | 26.83 | 1.00 | 2,838,090 | 13,416,342 | |
| 2018-04-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 9,476 | 9,476 | |||||
| 2018-03-07 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 1,530,423 | 0.01 | 25.00 | 2,500 | 38,260,575 | |
| 2018-03-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 15,000 | 1,530,323 | 0.99 | 24.84 | 372,600 | 38,013,223 | |
| 2018-03-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 15,000 | 1,515,323 | 1.00 | 25.15 | 377,250 | 38,110,373 | |
| 2018-03-01 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
P - Purchase | 10,000 | 626,142 | 1.62 | 62.59 | 625,910 | 39,190,854 | |
| 2018-02-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 13,165,028 | 0.08 | 25.21 | 252,100 | 331,890,356 | |
| 2018-02-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 13,155,028 | 0.08 | 25.16 | 251,600 | 330,980,504 | |
| 2018-02-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20,000 | 13,145,028 | 0.15 | 24.95 | 499,000 | 327,968,449 | |
| 2018-02-01 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 132 | 1,908 | 7.43 | ||||
| 2018-01-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
S - Sale | -12,000 | 3,414,053 | -0.35 | 48.50 | -582,031 | 165,590,447 | |
| 2018-01-09 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
S - Sale | -4,000 | 3,426,053 | -0.12 | 47.02 | -188,080 | 161,093,012 | |
| 2017-12-22 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
S - Sale | -500 | 3,365,053 | -0.01 | 46.00 | -23,000 | 154,792,438 | |
| 2017-12-22 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
S - Sale | -3,500 | 3,365,553 | -0.10 | 44.40 | -155,400 | 149,430,553 | |
| 2017-12-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
M - Exercise | -8,181 | 0 | -100.00 | ||||
| 2017-12-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
M - Exercise | -44,670 | 0 | -100.00 | ||||
| 2017-12-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 8,181 | 13,169,698 | 0.06 | 14.37 | 117,561 | 189,248,560 | |
| 2017-12-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 44,670 | 13,116,847 | 0.34 | 6.48 | 289,462 | 84,997,169 | |
| 2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -7,021 | 0 | -100.00 | ||||
| 2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -7,021 | 0 | -100.00 | ||||
| 2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -9,041 | 0 | -100.00 | ||||
| 2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -8,081 | 0 | -100.00 | ||||
| 2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
F - Taxes | -16,322 | 3,369,053 | -0.48 | 40.01 | -653,043 | 134,795,811 | |
| 2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 7,021 | 3,385,375 | 0.21 | 15.74 | 110,511 | 53,285,802 | |
| 2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 7,021 | 3,378,354 | 0.21 | 22.86 | 160,500 | 77,229,172 | |
| 2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 9,041 | 3,371,333 | 0.27 | 21.07 | 190,494 | 71,033,986 | |
| 2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 8,081 | 3,362,292 | 0.24 | 23.70 | 191,520 | 79,686,320 | |
| 2017-11-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 5,500 | 1,500,323 | 0.37 | 22.00 | 121,000 | 33,007,106 | |
| 2017-11-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 1,494,823 | 0.67 | 21.18 | 211,800 | 31,660,351 | |
| 2017-11-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 1,484,823 | 0.68 | 20.80 | 208,000 | 30,884,318 | |
| 2017-11-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 1,474,823 | 0.68 | 19.19 | 191,900 | 28,301,853 | |
| 2017-11-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20,000 | 1,464,823 | 1.38 | 18.98 | 379,600 | 27,802,341 | |
| 2017-11-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 24,581 | 1,444,823 | 1.73 | 18.81 | 462,369 | 27,177,121 | |
| 2017-11-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 26,600 | 1,420,242 | 1.91 | 18.54 | 493,164 | 26,331,287 | |
| 2017-11-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 50,000 | 1,393,642 | 3.72 | 18.46 | 923,000 | 25,726,631 | |
| 2017-11-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 50,000 | 1,343,642 | 3.87 | 18.73 | 936,500 | 25,166,415 | |
| 2017-11-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 1,293,642 | 0.01 | 19.00 | 1,900 | 24,579,198 | |
| 2017-11-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 340,864 | 1,293,542 | 35.78 | 18.51 | 6,309,393 | 23,943,462 | |
| 2017-11-01 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 141 | 1,776 | 8.62 | ||||
| 2017-10-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 45,000 | 13,040,117 | 0.35 | 20.14 | 906,300 | 262,627,956 | |
| 2017-10-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 13,250 | 12,995,117 | 0.10 | 20.29 | 268,842 | 263,670,924 | |
| 2017-10-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 59,922 | 12,981,867 | 0.46 | 20.07 | 1,202,635 | 260,546,071 | |
| 2017-10-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 32,060 | 12,954,005 | 0.25 | 19.72 | 632,223 | 255,452,979 | |
| 2017-10-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 29,240 | 12,921,945 | 0.23 | 18.81 | 550,004 | 243,061,785 | |
| 2017-10-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 276,200 | 12,892,705 | 2.19 | 19.74 | 5,452,188 | 254,501,997 | |
| 2017-10-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 51,600 | 12,616,505 | 0.41 | 20.27 | 1,045,932 | 255,736,556 | |
| 2017-09-05 |
|
4 | VRML |
VERMILLION, INC.
Warrants (Right to Buy) |
X - Other | -773,003 | 0 | -100.00 | ||||
| 2017-09-05 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
X - Other | 773,003 | 3,905,223 | 24.68 | 1.00 | 773,003 | 3,905,223 | |
| 2017-08-29 |
|
4 | VRML |
VERMILLION, INC.
Warrants (Right to Buy) |
P - Purchase | 773,003 | 773,003 | |||||
| 2017-08-29 |
|
4 | VRML |
VERMILLION, INC.
Warrants (Right to Buy) |
H - Other | -773,003 | 0 | -100.00 | ||||
| 2017-08-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 12,730 | 12,564,905 | 0.10 | 21.76 | 277,005 | 273,412,333 | |
| 2017-08-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 37,270 | 12,552,175 | 0.30 | 21.34 | 795,342 | 267,863,414 | |
| 2017-08-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 8,200 | 12,514,905 | 0.07 | 21.35 | 175,070 | 267,193,222 | |
| 2017-08-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 23,400 | 12,506,705 | 0.19 | 21.35 | 499,590 | 267,018,152 | |
| 2017-08-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 80,000 | 12,483,305 | 0.64 | 21.43 | 1,714,400 | 267,517,226 | |
| 2017-08-02 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock Warrants |
P - Purchase | 185,392 | 485,062 | 61.87 | 4.00 | 741,568 | 1,940,248 | |
| 2017-08-02 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 185,392 | 1,383,421 | 15.47 | 4.00 | 741,568 | 5,533,684 | |
| 2017-08-01 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 129 | 1,635 | 8.57 | ||||
| 2017-07-13 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 24,255 | 10,238,756 | 0.24 | 1.52 | 36,943 | 15,594,649 | |
| 2017-07-13 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 9,100 | 10,214,501 | 0.09 | 1.44 | 13,146 | 14,755,868 | |
| 2017-07-13 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 8,002 | 10,205,401 | 0.08 | 1.39 | 11,124 | 14,187,548 | |
| 2017-07-13 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 2,200 | 10,197,399 | 0.02 | 1.41 | 3,096 | 14,350,800 | |
| 2017-05-26 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
M - Exercise | -495 | 0 | -100.00 | ||||
| 2017-05-26 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
M - Exercise | 495 | 616,142 | 0.08 | ||||
| 2017-05-26 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 1,506 | 1,506 | |||||
| 2017-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Options |
A - Award | 5,065 | 5,065 | |||||
| 2017-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 2,016 | 2,016 | |||||
| 2017-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 485 | 485 | |||||
| 2017-04-04 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 11,721 | 11,721 | |||||
| 2017-02-17 | 3 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
4,677,342 | ||||||||
| 2017-02-17 | 3 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
4,677,342 | ||||||||
| 2017-02-15 |
|
4 | VRML |
VERMILLION, INC.
Warrants (Right to buy) |
P - Purchase | 730,560 | 730,560 | 0.12 | 91,320 | 91,320 | ||
| 2017-02-15 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
P - Purchase | 974,081 | 3,132,220 | 45.14 | 1.40 | 1,363,713 | 4,385,108 | |
| 2017-01-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 128,368 | 952,678 | 15.57 | 19.00 | 2,438,992 | 18,100,882 | |
| 2017-01-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 211,000 | 12,403,305 | 1.73 | 19.00 | 4,009,000 | 235,662,795 | |
| 2016-12-21 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -2,864 | 615,647 | -0.46 | ||||
| 2016-10-07 |
|
4/A | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 33,762 | 4,213,429 | 0.81 | 0.95 | 32,074 | 4,002,758 | |
| 2016-10-04 |
|
4 | BIOL |
BIOLASE, INC
Series C Participating Convertible Preferred Stock |
C - Conversion | -36,991 | 0 | -100.00 | ||||
| 2016-10-04 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
C - Conversion | 3,699,100 | 10,195,199 | 56.94 | 1.13 | 4,179,983 | 11,520,575 | |
| 2016-08-03 |
|
4 | BIOL |
BIOLASE, INC
Warrants (right to buy) |
P - Purchase | 850,796 | 850,796 | 0.12 | 106,350 | 106,350 | ||
| 2016-08-03 |
|
4 | BIOL |
BIOLASE, INC
Series C Participating Convertible Preferred Stock |
P - Purchase | 36,991 | 36,991 | 113.00 | 4,179,983 | 4,179,983 | ||
| 2016-07-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 12,192,305 | 0.08 | 13.99 | 139,900 | 170,570,347 | |
| 2016-07-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 80,147 | 12,182,305 | 0.66 | 13.94 | 1,117,249 | 169,821,332 | |
| 2016-06-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 14,033 | 12,102,158 | 0.12 | 13.67 | 191,831 | 165,436,500 | |
| 2016-06-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 15,967 | 12,088,125 | 0.13 | 13.70 | 218,748 | 165,607,312 | |
| 2016-06-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1,000 | 12,072,158 | 0.01 | 15.00 | 15,000 | 181,082,370 | |
| 2016-06-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 87,316 | 824,310 | 11.85 | 14.69 | 1,282,672 | 12,109,114 | |
| 2016-06-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 75,000 | 736,994 | 11.33 | 14.17 | 1,062,750 | 10,443,205 | |
| 2016-06-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 26,272 | 661,994 | 4.13 | 14.07 | 369,647 | 9,314,256 | |
| 2016-05-31 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Put Option (obligation to buy) |
E - Other | -9,000 | 0 | -100.00 | ||||
| 2016-05-27 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 495 | 495 | |||||
| 2016-05-27 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3,713 | 3,713 | |||||
| 2016-05-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 4,270 | 12,071,158 | 0.04 | 11.04 | 47,141 | 133,265,584 | |
| 2016-05-19 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 7,021 | 7,021 | |||||
| 2016-05-19 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 962 | 962 | |||||
| 2016-05-19 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 908 | 908 | |||||
| 2016-05-19 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 3,027 | 3,027 | |||||
| 2016-05-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 12,066,888 | 0.08 | 11.45 | 114,500 | 138,165,868 | |
| 2016-05-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 11,511 | 12,056,888 | 0.10 | 11.91 | 137,096 | 143,597,536 | |
| 2016-05-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20,000 | 12,045,377 | 0.17 | 12.45 | 249,000 | 149,964,944 | |
| 2016-04-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 8,181 | 74,937 | 12.26 | ||||
| 2016-02-22 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 500 | 6,547,537 | 0.01 | 0.80 | 400 | 5,238,030 | |
| 2016-02-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Put Option (obligation to buy) |
S - Sale | -9,000 | 9,000 | -50.00 | 100.00 | -900,000 | 900,000 | |
| 2016-02-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 900 | 6,547,037 | 0.01 | 0.80 | 720 | 5,237,630 | |
| 2016-02-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 3,200 | 6,546,137 | 0.05 | 0.80 | 2,554 | 5,224,472 | |
| 2016-02-16 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 500 | 6,542,937 | 0.01 | 0.78 | 388 | 5,083,862 | |
| 2016-02-16 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 18,580 | 6,542,437 | 0.28 | 0.76 | 14,041 | 4,944,120 | |
| 2016-02-11 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 54,187 | 6,523,857 | 0.84 | 0.77 | 41,952 | 5,050,770 | |
| 2016-02-11 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 13,026 | 6,469,670 | 0.20 | 0.79 | 10,285 | 5,108,451 | |
| 2016-02-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 76,790 | 12,032,376 | 0.64 | 10.63 | 816,278 | 127,904,157 | |
| 2016-02-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 600,000 | 11,955,586 | 5.28 | 11.86 | 7,116,000 | 141,793,250 | |
| 2016-02-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20,000 | 11,355,586 | 0.18 | 12.32 | 246,400 | 139,900,820 | |
| 2016-02-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 7,308 | 11,335,586 | 0.06 | 12.65 | 92,446 | 143,395,163 | |
| 2016-02-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 11,328,278 | 0.09 | 12.98 | 129,800 | 147,041,048 | |
| 2016-02-04 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 50,100 | 11,318,278 | 0.44 | 13.09 | 655,809 | 148,156,259 | |
| 2016-02-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20,000 | 11,268,178 | 0.18 | 13.46 | 269,200 | 151,669,676 | |
| 2016-02-01 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 1,493 | 2,158,139 | 0.07 | 1.60 | 2,389 | 3,453,022 | |
| 2016-01-28 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 1,750 | 2,156,646 | 0.08 | 1.59 | 2,782 | 3,429,067 | |
| 2016-01-28 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 700 | 2,154,896 | 0.03 | 1.60 | 1,120 | 3,447,834 | |
| 2016-01-27 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 1,400 | 6,456,644 | 0.02 | 0.80 | 1,120 | 5,165,315 | |
| 2016-01-26 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 2,400 | 2,154,196 | 0.11 | 1.59 | 3,816 | 3,425,172 | |
| 2016-01-26 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 1,300 | 2,151,796 | 0.06 | 1.53 | 1,989 | 3,292,248 | |
| 2016-01-25 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 1,870 | 6,455,244 | 0.03 | 0.77 | 1,444 | 4,983,448 | |
| 2016-01-25 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 4,800 | 6,453,374 | 0.07 | 0.78 | 3,740 | 5,027,824 | |
| 2016-01-22 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 6,000 | 2,150,496 | 0.28 | 1.53 | 9,180 | 3,290,259 | |
| 2016-01-22 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 24,700 | 2,144,496 | 1.17 | 1.44 | 35,568 | 3,088,074 | |
| 2016-01-21 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 19,900 | 6,448,574 | 0.31 | 0.74 | 14,660 | 4,750,664 | |
| 2016-01-21 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 4,300 | 6,428,674 | 0.07 | 0.79 | 3,396 | 5,076,724 | |
| 2016-01-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 11,248,178 | 0.09 | 15.02 | 150,200 | 168,947,634 | |
| 2016-01-20 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 57,749 | 2,119,796 | 2.80 | 1.45 | 83,736 | 3,073,704 | |
| 2016-01-20 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 8,400 | 2,062,047 | 0.41 | 1.56 | 13,104 | 3,216,793 | |
| 2015-12-29 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 18,350 | 6,424,374 | 0.29 | 0.79 | 14,473 | 5,066,904 | |
| 2015-12-28 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 3,100 | 6,406,024 | 0.05 | 0.75 | 2,322 | 4,797,471 | |
| 2015-12-28 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 38,800 | 6,402,924 | 0.61 | 0.76 | 29,391 | 4,850,215 | |
| 2015-12-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2,500 | 11,231,179 | 0.02 | 18.20 | 45,500 | 204,407,458 | |
| 2015-12-23 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 87,200 | 6,364,124 | 1.39 | 0.74 | 64,511 | 4,708,179 | |
| 2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -165 | 618,511 | -0.03 | ||||
| 2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -6,722 | 618,676 | -1.07 | ||||
| 2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -71,800 | 625,398 | -10.30 | ||||
| 2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -15 | 697,198 | 0.00 | ||||
| 2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -36 | 697,213 | -0.01 | ||||
| 2015-12-22 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 126,919 | 6,276,924 | 2.06 | 0.73 | 93,184 | 4,608,518 | |
| 2015-12-22 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 973 | 6,150,005 | 0.02 | 0.68 | 662 | 4,185,693 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 64,865 | 5,885,603 | 1.11 | 0.93 | 60,324 | 5,473,611 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 200 | 5,820,738 | 0.00 | 0.95 | 190 | 5,529,701 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5,400 | 5,820,538 | 0.09 | 0.95 | 5,130 | 5,529,511 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 93,409 | 5,815,138 | 1.63 | 0.86 | 80,332 | 5,001,019 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 234,313 | 5,721,729 | 4.27 | 0.78 | 182,764 | 4,462,949 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 33,099 | 5,487,416 | 0.61 | 0.77 | 25,486 | 4,225,310 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 140,000 | 5,454,317 | 2.63 | 0.63 | 88,200 | 3,436,220 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 505,974 | 5,314,317 | 10.52 | 0.77 | 389,600 | 4,092,024 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5,671 | 4,808,343 | 0.12 | 0.90 | 5,104 | 4,327,509 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 9,900 | 4,802,672 | 0.21 | 0.91 | 9,009 | 4,370,432 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 23,500 | 4,792,772 | 0.49 | 0.92 | 21,620 | 4,409,350 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 48,250 | 4,769,272 | 1.02 | 0.92 | 44,390 | 4,387,730 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 541,355 | 4,721,022 | 12.95 | 0.92 | 498,047 | 4,343,340 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 52,103 | 4,179,667 | 1.26 | 0.95 | 49,498 | 3,970,684 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 25,510 | 4,127,564 | 0.62 | 0.95 | 24,234 | 3,921,186 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 1,000 | 4,102,054 | 0.02 | 0.96 | 960 | 3,937,972 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 2,970 | 4,101,054 | 0.07 | 0.96 | 2,851 | 3,937,012 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 13,418 | 4,098,084 | 0.33 | 0.96 | 12,881 | 3,934,161 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 100,000 | 4,084,666 | 2.51 | 0.99 | 99,000 | 4,043,819 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 14,800 | 14,800 | 1.03 | 15,244 | 15,244 | ||
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 100,000 | 3,984,666 | 2.57 | 1.03 | 103,000 | 4,104,206 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 1,100,000 | 3,884,666 | 39.50 | 0.95 | 1,045,000 | 3,690,433 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 500 | 2,784,666 | 0.02 | 0.90 | 450 | 2,506,199 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 169,361 | 2,784,166 | 6.48 | 0.89 | 150,731 | 2,477,908 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 10,639 | 2,614,805 | 0.41 | 0.93 | 9,894 | 2,431,769 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 28,000 | 6,114,874 | 0.46 | 0.72 | 20,160 | 4,402,709 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 42,923 | 6,086,874 | 0.71 | 0.74 | 31,763 | 4,504,287 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 7,078 | 6,043,951 | 0.12 | 0.77 | 5,450 | 4,653,842 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 31,699 | 6,036,873 | 0.53 | 0.78 | 24,725 | 4,708,761 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5,704 | 6,005,174 | 0.10 | 0.79 | 4,506 | 4,744,087 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 14,596 | 5,999,470 | 0.24 | 0.79 | 11,531 | 4,739,581 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 8,561 | 5,984,874 | 0.14 | 0.80 | 6,849 | 4,787,899 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5,286 | 5,976,313 | 0.09 | 0.81 | 4,282 | 4,840,814 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 16,427 | 5,971,027 | 0.28 | 0.81 | 13,306 | 4,836,532 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5,900 | 5,954,600 | 0.10 | 0.85 | 5,015 | 5,061,410 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 16,752 | 5,948,700 | 0.28 | 0.90 | 15,077 | 5,353,830 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 2,045 | 5,931,948 | 0.03 | 0.89 | 1,820 | 5,279,434 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 44,200 | 5,929,903 | 0.75 | 0.90 | 39,780 | 5,336,913 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 100 | 5,885,703 | 0.00 | 0.92 | 92 | 5,414,847 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 9,558 | 6,149,032 | 0.16 | 0.70 | 6,691 | 4,304,322 | |
| 2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 24,600 | 6,139,474 | 0.40 | 0.70 | 17,338 | 4,327,101 | |
| 2015-12-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2,352,941 | 11,238,178 | 26.48 | 17.00 | 39,999,997 | 191,049,026 | |
| 2015-11-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 11,899 | 10,890,669 | 0.11 | 16.81 | 200,022 | 183,072,146 | |
| 2015-11-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 51,337 | 10,878,770 | 0.47 | 16.80 | 862,462 | 182,763,336 | |
| 2015-11-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1,500 | 10,827,433 | 0.01 | 17.00 | 25,500 | 184,066,361 | |
| 2015-10-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1,860 | 10,825,933 | 0.02 | 15.86 | 29,500 | 171,699,297 | |
| 2015-10-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 300 | 10,824,073 | 0.00 | 15.60 | 4,680 | 168,855,539 | |
| 2015-10-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 40,600 | 10,823,773 | 0.38 | 15.18 | 616,308 | 164,304,874 | |
| 2015-08-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 10,773,173 | 0.09 | 18.56 | 185,600 | 199,950,091 | |
| 2015-08-26 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 10,783,173 | 0.09 | 17.81 | 178,100 | 192,048,311 | |
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | -100,000 | 0 | -100.00 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | -100,000 | 0 | -100.00 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | -100,000 | 100,000 | -50.00 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | -100,000 | 200,000 | -33.33 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | -100,000 | 300,000 | -25.00 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | -1,880,000 | 500,000 | -78.99 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series B-1 Preferred Stock |
C - Conversion | -453,982 | 0 | -100.00 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -173,009 | 0 | -100.00 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
P - Purchase | 20,000 | 1,279,903 | 1.59 | 15.00 | 300,000 | 19,198,545 | |
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41,665 | 1,252,903 | 3.44 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41,665 | 1,252,903 | 3.44 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41,665 | 1,252,903 | 3.44 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41,665 | 1,211,238 | 3.56 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41,665 | 1,127,908 | 3.84 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 783,332 | 1,044,578 | 299.84 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 189,159 | 261,246 | 262.40 | ||||
| 2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 72,087 | 72,087 | |||||
| 2015-07-21 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 765,308 | 2,053,647 | 59.40 | 1.96 | 1,500,004 | 4,025,148 | |
| 2015-06-23 |
|
4 | MBLX |
METABOLIX, INC.
Common Stock Warrants |
P - Purchase | 1,498,356 | 1,498,356 | 0.12 | 187,294 | 187,294 | ||
| 2015-06-23 |
|
4 | MBLX |
METABOLIX, INC.
Common Stock |
P - Purchase | 1,664,840 | 2,185,652 | 319.66 | 3.32 | 5,527,269 | 7,256,365 | |
| 2015-06-15 |
|
4 | HNSN |
HANSEN MEDICAL INC
Stock Option (Right to Buy) |
A - Award | 60,000 | 60,000 | |||||
| 2015-05-29 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 4,931 | 4,931 | |||||
| 2015-05-06 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 7,021 | 7,021 | |||||
| 2015-05-06 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 962 | 962 | |||||
| 2015-05-06 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 625 | 625 | |||||
| 2015-05-06 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 2,084 | 2,084 | |||||
| 2015-04-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 9,000 | 10,772,173 | 0.08 | 21.85 | 196,650 | 235,371,980 | |
| 2015-04-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2,000 | 10,763,173 | 0.02 | 22.33 | 44,660 | 240,341,653 | |
| 2015-04-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 7,658 | 66,756 | 12.96 | ||||
| 2015-03-17 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 4,000 | 10,761,173 | 0.04 | 20.55 | 82,200 | 221,142,105 | |
| 2015-03-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 22,584 | 10,757,173 | 0.21 | 17.18 | 387,993 | 184,808,232 | |
| 2015-01-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 3,000 | 10,734,589 | 0.03 | 18.27 | 54,810 | 196,120,941 | |
| 2015-01-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 5,000 | 10,731,589 | 0.05 | 18.43 | 92,150 | 197,783,185 | |
| 2015-01-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 10,726,589 | 0.09 | 19.37 | 193,700 | 207,774,029 | |
| 2014-12-29 |
|
4 | VRML |
VERMILLION, INC.
Warrant to acquire Common Stock |
P - Purchase | 773,003 | 773,003 | 0.12 | 96,625 | 96,625 | ||
| 2014-12-29 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 1,288,339 | 1,288,339 | 1.44 | 1,855,208 | 1,855,208 | ||
| 2014-12-23 |
|
4 | VRML |
VERMILLION, INC.
Warrant to Acquire Common Stock |
X - Other | 4,055,157 | 0 | -100.00 | ||||
| 2014-12-23 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
X - Other | 4,055,157 | 6,673,029 | 154.90 | 1.46 | 5,920,529 | 9,742,622 | |
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -39 | 697,249 | -0.01 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -62 | 697,288 | -0.01 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -1,028 | 697,350 | -0.15 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -345 | 698,378 | -0.05 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -1,688 | 698,723 | -0.24 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -40 | 700,411 | -0.01 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -37 | 700,451 | -0.01 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -30 | 700,488 | 0.00 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -44 | 700,518 | -0.01 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -44 | 700,562 | -0.01 | ||||
| 2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -43 | 700,606 | -0.01 | ||||
| 2014-11-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 9,041 | 9,041 | |||||
| 2014-11-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 417 | 417 | |||||
| 2014-11-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 678 | 678 | |||||
| 2014-11-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 2,261 | 2,261 | |||||
| 2014-11-13 | 3 | BIOL |
BIOLASE, INC
Common Stock |
5,208,332 | ||||||||
| 2014-11-13 | 3 | BIOL |
BIOLASE, INC
Common Stock |
5,208,332 | ||||||||
| 2014-09-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2,588 | 10,716,589 | 0.02 | 16.44 | 42,547 | 176,180,723 | |
| 2014-09-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 31,910 | 10,714,001 | 0.30 | 16.67 | 531,940 | 178,602,397 | |
| 2014-09-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 501 | 10,682,091 | 0.00 | 16.80 | 8,417 | 179,459,129 | |
| 2014-08-25 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2,900 | 10,681,590 | 0.03 | 16.79 | 48,691 | 179,343,896 | |
| 2014-07-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20,000 | 10,678,690 | 0.19 | 19.89 | 397,800 | 212,399,144 | |
| 2014-07-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 8,698 | 10,658,690 | 0.08 | 25.70 | 223,539 | 273,928,333 | |
| 2014-07-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10,000 | 10,649,992 | 0.09 | 26.09 | 260,900 | 277,858,291 | |
| 2014-05-23 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 4,359 | 4,359 | |||||
| 2014-05-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 863,072 | 10,639,992 | 8.83 | 16.80 | 14,499,610 | 178,751,866 | |
| 2014-05-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Subscription Rights (right to buy) |
X - Other | -587,401 | 0 | -100.00 | ||||
| 2014-05-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
X - Other | 587,401 | 9,776,920 | 6.39 | 16.80 | 9,868,337 | 164,252,256 | |
| 2014-04-30 |
|
4 | HNSN |
HANSEN MEDICAL INC
Stock Option (Right to Buy) |
A - Award | 30,000 | 30,000 | |||||
| 2014-04-07 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 14,428 | 59,098 | 32.30 | ||||
| 2014-03-21 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
S - Sale | -638,639 | 6,165,261 | -9.39 | 1.79 | -1,143,164 | 11,035,817 | |
| 2014-03-21 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
S - Sale | -115,492 | 6,803,900 | -1.67 | 1.90 | -219,435 | 12,927,410 | |
| 2014-03-21 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
S - Sale | -438,120 | 6,919,392 | -5.95 | 1.91 | -836,809 | 13,216,039 | |
| 2014-02-28 |
|
4 | HNSN |
HANSEN MEDICAL INC
Warrant (Right to Buy) |
X - Other | -3,744,094 | 0 | -100.00 | ||||
| 2014-02-28 |
|
4 | HNSN |
HANSEN MEDICAL INC
Common Stock |
X - Other | 3,744,094 | 13,233,640 | 39.45 | 1.23 | 4,605,236 | 16,277,377 | |
| 2013-12-31 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -900 | 700,649 | -0.13 | ||||
| 2013-12-30 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -18,630 | 701,549 | -2.59 | ||||
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -7,105 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -9,433 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -7,033 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -3,226 | 147,967 | -2.13 | 96.40 | -310,986 | 14,264,019 | |
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -3,226 | 147,967 | -2.13 | 96.40 | -310,986 | 14,264,019 | |
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
F - Taxes | -3,676 | 720,179 | -0.51 | 113.69 | -417,924 | 81,877,151 | |
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
M - Exercise | 7,105 | 723,855 | 0.99 | 58.82 | 417,916 | 42,577,151 | |
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
F - Taxes | -3,079 | 716,750 | -0.43 | 113.69 | -350,052 | 81,487,308 | |
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
M - Exercise | 7,033 | 719,829 | 0.99 | 49.76 | 349,962 | 35,818,691 | |
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
F - Taxes | -4,704 | 712,796 | -0.66 | 113.69 | -534,798 | 81,037,777 | |
| 2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
M - Exercise | 9,433 | 717,500 | 1.33 | 56.70 | 534,851 | 40,682,250 | |
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -7,800 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -7,800 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -14,449 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -16,002 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -12,154 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -9,331 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | -9,331 | 0 | -100.00 | ||||
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
F - Taxes | -37,713 | 3,354,207 | -1.11 | 27.54 | -1,038,616 | 92,374,861 | |
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 7,800 | 3,391,920 | 0.23 | 15.73 | 122,694 | 53,354,902 | |
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 7,800 | 3,384,120 | 0.23 | 14.43 | 112,554 | 48,832,852 | |
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 14,449 | 3,376,320 | 0.43 | 13.25 | 191,449 | 44,736,240 | |
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 16,002 | 3,361,871 | 0.48 | 11.96 | 191,384 | 40,207,977 | |
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 12,154 | 3,345,869 | 0.36 | 16.25 | 197,502 | 54,370,371 | |
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 9,331 | 3,333,715 | 0.28 | 13.97 | 130,354 | 46,571,999 | |
| 2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 9,331 | 3,324,384 | 0.28 | 9.93 | 92,657 | 33,011,133 | |
| 2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 500 | 9,189,519 | 0.01 | 13.14 | 6,570 | 120,750,280 | |
| 2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 500 | 9,189,019 | 0.01 | 13.02 | 6,510 | 119,641,027 | |
| 2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 300 | 9,188,519 | 0.00 | 12.89 | 3,867 | 118,440,010 | |
| 2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 9,188,219 | 0.00 | 12.84 | 1,284 | 117,976,732 | |
| 2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 9,188,119 | 0.00 | 12.82 | 1,282 | 117,791,686 | |
| 2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 3,000 | 9,188,019 | 0.03 | 12.30 | 36,900 | 113,012,634 | |
| 2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 6,900 | 9,185,019 | 0.08 | 12.27 | 84,663 | 112,700,183 | |
| 2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 9,178,119 | 0.00 | 12.26 | 1,226 | 112,523,739 | |
| 2013-08-26 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
P - Purchase | 93,777 | 7,357,512 | 1.29 | 1.36 | 127,565 | 10,008,424 | |
| 2013-08-22 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
P - Purchase | 199,586 | 7,263,735 | 2.83 | 1.40 | 278,961 | 10,152,522 | |
| 2013-08-22 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
P - Purchase | 110,005 | 7,064,149 | 1.58 | 1.45 | 159,518 | 10,243,722 | |
| 2013-08-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 800 | 9,178,019 | 0.01 | 7.97 | 6,376 | 73,148,811 | |
| 2013-08-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 46,246 | 9,177,219 | 0.51 | 8.00 | 369,968 | 73,417,752 | |
| 2013-08-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 32,248 | 9,130,973 | 0.35 | 7.72 | 248,955 | 70,491,112 | |
| 2013-08-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 413,090 | 9,098,725 | 4.76 | 8.04 | 3,321,244 | 73,153,749 | |
| 2013-08-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Subscription Rights (right to buy) |
O - Other | -515,056 | 0 | -100.00 | ||||
| 2013-08-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
O - Other | 642,631 | 8,685,635 | 7.99 | 8.04 | 5,166,753 | 69,832,505 | |
| 2013-08-12 |
|
4 | HNSN |
HANSEN MEDICAL INC
Stock Option (Right to Buy) |
A - Award | 50,000 | 50,000 | |||||
| 2013-08-12 | 3 | HNSN |
HANSEN MEDICAL INC
Common Stock |
5,319,769 | ||||||||
| 2013-08-12 | 3 | HNSN |
HANSEN MEDICAL INC
Common Stock |
9,489,546 | ||||||||
| 2013-08-12 | 3 | HNSN |
HANSEN MEDICAL INC
Common Stock |
16,000 | ||||||||
| 2013-07-12 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -946 | 27,110 | -3.37 | 105.75 | -100,035 | 2,866,750 | |
| 2013-07-12 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -946 | 365,399 | -0.26 | 105.75 | -100,038 | 38,640,360 | |
| 2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | -10,645 | 21,910 | -32.70 | 48.93 | -520,869 | 1,072,076 | |
| 2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | -10,645 | 21,910 | -32.70 | 48.93 | -520,869 | 1,072,076 | |
| 2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | -10,685 | 21,840 | -32.85 | 48.93 | -522,827 | 1,068,651 | |
| 2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | -745 | 32,555 | -2.24 | 38.52 | -28,697 | 1,254,019 | |
| 2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | -5 | 32,525 | -0.02 | 38.26 | -191 | 1,244,406 | |
| 2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | -770 | 32,530 | -2.31 | 38.50 | -29,645 | 1,252,405 | |
| 2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | -735 | 32,565 | -2.21 | 38.50 | -28,298 | 1,253,752 | |
| 2013-05-23 | 3 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
2,617,872 | ||||||||
| 2013-05-22 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 5,245 | 5,245 | |||||
| 2013-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 371 | 371 | |||||
| 2013-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 8,081 | 8,081 | |||||
| 2013-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium |
A - Award | 603 | 603 | |||||
| 2013-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Rstricted Stock Units (Converted) |
A - Award | 2,010 | 2,010 | |||||
| 2013-05-01 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
A - Award | 2,989 | 536,088 | 0.56 | ||||
| 2013-04-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 44,670 | 44,670 | |||||
| 2013-03-27 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -955 | 393,455 | -0.24 | 103.94 | -99,259 | 40,894,218 | |
| 2013-03-27 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -925 | 860,216 | -0.11 | 103.92 | -96,126 | 89,393,389 | |
| 2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Warrants (right to buy) |
J - Other | -571,160 | 0 | -100.00 | ||||
| 2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Warrants (right to buy) |
X - Other | -6,428,840 | 571,160 | -91.84 | ||||
| 2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Warrants (right to buy) |
X - Other | -7,000,000 | 7,000,000 | -50.00 | ||||
| 2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 8,043,004 | 8,043,004 | |||||
| 2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | -14,000,000 | 0 | -100.00 | ||||
| 2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | -13,428,840 | 14,000,000 | -48.96 | ||||
| 2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
X - Other | 6,428,840 | 27,428,840 | 30.61 | 2.00 | 12,857,680 | 54,857,680 | |
| 2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
X - Other | 7,000,000 | 21,000,000 | 50.00 | 1.03 | 7,210,000 | 21,630,000 | |
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -3,521 | 861,141 | -0.41 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -212,000 | 864,662 | -19.69 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -100,000 | 1,275,104 | -7.27 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -3,124 | 1,375,104 | -0.23 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | 10,800 | 394,410 | 2.82 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -10,800 | 1,378,228 | -0.78 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | 16,300 | 383,610 | 4.44 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -16,300 | 29,340 | -35.71 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -45,000 | 1,389,028 | -3.14 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -5,000 | 1,434,028 | -0.35 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -51,070 | 1,539,018 | -3.21 | ||||
| 2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | -270 | 1,590,088 | -0.02 | ||||
| 2012-12-14 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -29,973 | 1,291,916 | -2.27 | 93.31 | -2,796,781 | 120,548,682 | |
| 2012-12-14 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -85,853 | 1,321,889 | -6.10 | 93.38 | -8,016,953 | 123,437,995 | |
| 2012-12-14 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -82,616 | 1,407,742 | -5.54 | 94.26 | -7,787,384 | 132,693,761 | |
| 2012-09-13 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -50,000 | 1,490,358 | -3.25 | 93.32 | -4,666,000 | 139,080,209 | |
| 2012-09-13 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | -50,000 | 1,540,358 | -3.14 | 92.98 | -4,649,000 | 143,222,487 | |
| 2012-07-03 |
|
4 | AXK |
ACCELR8 TECHNOLOGY CORP
Warrants (right to buy) |
P - Purchase | 7,000,000 | 14,000,000 | 100.00 | ||||
| 2012-07-03 |
|
4 | AXK |
ACCELR8 TECHNOLOGY CORP
Warrants (right to buy) |
P - Purchase | 7,000,000 | 14,000,000 | 100.00 | ||||
| 2012-07-03 |
|
4 | AXK |
ACCELR8 TECHNOLOGY CORP
Common Stock |
P - Purchase | 14,000,000 | 14,000,000 | 1.03 | 14,420,000 | 14,420,000 | ||
| 2012-07-03 | 3 | AXK |
ACCELR8 TECHNOLOGY CORP
Common Stock |
14,000,000 | ||||||||
| 2012-05-23 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 5,960 | 5,960 | |||||
| 2012-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 2,600 | 2,600 | |||||
| 2012-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 7,800 | 7,800 | |||||
| 2012-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 740 | 740 | |||||
| 2012-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 2,469 | 2,469 | |||||
| 2012-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restrict Stock Units (Equity Grant) |
M - Exercise | -2,600 | 0 | -100.00 | ||||
| 2012-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 2,600 | 3,315,053 | 0.08 | ||||
| 2012-05-02 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
A - Award | 3,665 | 532,484 | 0.69 | ||||
| 2012-03-21 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
P - Purchase | 40,000 | 3,311,465 | 1.22 | 16.65 | 665,928 | 55,129,932 | |
| 2012-03-21 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
P - Purchase | 15,815 | 3,271,465 | 0.49 | 16.48 | 260,577 | 53,902,620 | |
| 2012-03-21 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
P - Purchase | 10,000 | 3,255,650 | 0.31 | 16.60 | 165,954 | 54,028,814 | |
| 2012-03-05 |
|
4 | GTXI |
GTX INC /DE/
common stock |
P - Purchase | 796,923 | 6,954,144 | 12.94 | 3.33 | 2,653,754 | 23,157,300 | |
| 2012-03-05 |
|
4 | GTXI |
GTX INC /DE/
common stock |
P - Purchase | 69,700 | 5,632,320 | 1.25 | 3.33 | 232,101 | 18,755,626 | |
| 2012-03-05 |
|
4/A | GTXI |
GTX INC /DE/
common stock |
P - Purchase | 69,700 | 6,157,221 | 1.14 | 3.33 | 232,101 | 20,503,546 | |
| 2012-01-18 | 3 | MBLX |
METABOLIX, INC.
common stock, par value $.01 per share |
3,124,876 | ||||||||
| 2012-01-18 | 3 | MBLX |
METABOLIX, INC.
common stock, par value $.01 per share |
50,600 | ||||||||
| 2012-01-18 | 3 | MBLX |
METABOLIX, INC.
common stock, par value $.01 per share |
1,915,819 | ||||||||
| 2009-01-23 |
|
5 | QDEL |
QUIDEL CORP /DE/
Common Stock |
G - Gift | -296 | 2,667,288 | -0.01 | ||||
| 2009-01-23 |
|
5 | QDEL |
QUIDEL CORP /DE/
Common Stock |
G - Gift | -962 | 2,667,584 | -0.04 | ||||
| 2009-01-23 |
|
5 | QDEL |
QUIDEL CORP /DE/
Common Stock |
G - Gift | -185 | 2,668,546 | -0.01 | ||||
| 2009-01-23 |
|
5 | QDEL |
QUIDEL CORP /DE/
Common Stock |
G - Gift | -11,218 | 2,668,731 | -0.42 | ||||
| 2006-02-07 | 3 | QDEL |
QUIDEL CORP /DE/
Common Stock |
3,137,058 | ||||||||
| 2006-02-07 | 3 | QDEL |
QUIDEL CORP /DE/
Common Stock |
225,756 |
